Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00951028 · ClinicalTrials.gov registry record · NA
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT00951028: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00951028 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00951028, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
This study will test a therapy for both helping people adhere to their HIV medication regimens and treating them for depression.
Primary Outcome
HIV medication adherence is assessed more frequently during the acute study period (baseline to post-treatment), and then at the follow up major visits.
Interventions
- BEHAVIORAL Cognitive behavioral therapy (CBT) for adherence and depression (CBT-AD)
- BEHAVIORAL Life-steps adherence treatment
- BEHAVIORAL Information and supportive psychotherapy (ISP) for adherence and depression (ISP-AD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT00951028 record still lists
NCT00951028 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 3 interventions - of which Cognitive behavioral therapy (CBT) for adherence and depression (CBT-AD) is the first listed.
NCT00951028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00951028 about?
NCT00951028 is a clinical study titled "Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)". This study will test a therapy for both helping people adhere to their HIV medication regimens and treating them for depression.
What is the current status of trial NCT00951028?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2008-09. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00951028?
The interventions under investigation include: Cognitive behavioral therapy (CBT) for adherence and depression (CBT-AD) (BEHAVIORAL), Life-steps adherence treatment (BEHAVIORAL), Information and supportive psychotherapy (ISP) for adherence and depression (ISP-AD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00951028?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00951028's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia